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ScopolamineNeuroimaging data are increasingly being used to predict potential outcomes or groupings, such as clinical
severity, drug dose response, and transitional illness states. In these examples, the variable (target) we
want to predict is ordinal in nature. Conventional classiﬁcation schemes assume that the targets are nominal
and hence ignore their ranked nature, whereas parametric and/or non-parametric regression models enforce
a metric notion of distance between classes. Here, we propose a novel, alternative multivariate approach that
overcomes these limitations — whole brain probabilistic ordinal regression using a Gaussian process frame-
work. We applied this technique to two data sets of pharmacological neuroimaging data from healthy volun-
teers. The ﬁrst study was designed to investigate the effect of ketamine on brain activity and its subsequent
modulation with two compounds — lamotrigine and risperidone. The second study investigates the effect of
scopolamine on cerebral blood ﬂow and its modulation using donepezil. We compared ordinal regression to
multi-class classiﬁcation schemes and metric regression. Considering the modulation of ketamine with
lamotrigine, we found that ordinal regression signiﬁcantly outperformed multi-class classiﬁcation and metric
regression in terms of accuracy and mean absolute error. However, for risperidone ordinal regression signif-
icantly outperformed metric regression but performed similarly to multi-class classiﬁcation both in terms of
accuracy and mean absolute error. For the scopolamine data set, ordinal regression was found to outperform
both multi-class and metric regression techniques considering the regional cerebral blood ﬂow in the anteri-
or cingulate cortex. Ordinal regression was thus the only method that performed well in all cases. Our results
indicate the potential of an ordinal regression approach for neuroimaging data while providing a fully prob-
abilistic framework with elegant approaches for model selection.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. Introduction
Neuroimaging can be used to investigate a wide range of clinical
and research questions including disease processes (Fusar-Poli et al.,
in press; Jack et al., 2008) and decode both instantaneous cognitive
states (Friston et al., 2008) and pharmacological intervention
(Deakin et al., 2008). Increasingly, multivariate pattern recognition
techniques are being applied to neuroimaging data to answer funda-
mental questions based around diagnosis/prognosis and decoding.
Primarily, this can be achieved by training a learning machine using
a subset of the data and their respective targets (e.g. clinical measure
or state label) and observing the accuracy of the target assigned to
a set of ‘unseen’ data, which serves to estimate the generalisationj.ashburner@ucl.ac.uk
steve.williams@kcl.ac.uk
andre.marquand@kcl.ac.uk
nc. Open access under CC BY license. performance of the learner. Most commonly, learning machines are
used to perform binary classiﬁcation whereby only two labels or
states are considered and the classes are assumed to have a nominal
relationship to one another (e.g. patient vs. control or placebo vs.
drug). To date, the most popular approach has been the binary sup-
port vector machine classiﬁer (Fan et al., 2007; Mourao-Miranda et
al., 2012; Pantazatos et al., 2012; Plant et al., 2010).
In order to consider more than two labels, multi-class learning can
be employed. To performmulti-class classiﬁcation a common approach,
in the ﬁeld of neuroimaging, has been to split the problem up into a
series of binary classiﬁcation problems and then apply combination
strategies such as error correcting codes (Hassabis et al., 2009;
Mourao-Miranda et al., 2006; Schrouff et al., 2012) or “one-versus-all”
(Chu et al., 2011; Zheng et al., 2013). Alternatively, several studies
have focused on the use of a single learningmachine in order to consid-
er all classes in amutual context. Marquand et al. (2012) applied sparse
multinomial logistic regression to pharmacological imaging data in
order to discriminate cerebral blood ﬂow maps collected using arterial
spin labelling after placebo, atomoxetine and methylphenidate
administration. Filippone et al. (2013) used an inherently multi-class
Gaussian process classiﬁcation approach for neuroimaging data to dis-
criminate between different Parkinsonian neurological disorders and
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several sparse methods using both an inherently multi-class likelihood
and a “one-versus-all” approach to discriminate the mental representa-
tion of different objects. The authors conclude that the best performance
was achieved using a multinomial likelihood within their framework.
For many applications of neuroimaging, the class labels can be
ordered or ranked, but it can be difﬁcult to exactly quantify the distance
between the categories. One example is a disease process continuum
where the labels of scans can be ordered as: healthy controls, prodromal
and disease state. The most cited example in the neuroimaging litera-
ture being the Alzheimer's Disease Neuroimaging Initiative (ADNI)
data set which contains neuroimaging and clinical data from partici-
pants with Alzheimer's disease, progressive mild cognitive impairment,
stablemild cognitive impairment and thosewho are cognitively normal
(Mueller et al., 2005). Similarly, there is a lot of interest in identifying
andmonitoring individuals at risk of psychosis,whomay be in a prodro-
mal phase of the disease (Fusar-Poli et al., in press). For example,
Borgwardt et al. (in press) analysed structuralMRI scans froma psycho-
sis continuum (healthy controls–at risk–ﬁrst-episode psychosis) albeit
using binary pairs of classiﬁers.
In addition to disease trajectories, continuum models are also evi-
dent in several other applications of neuroimaging. Increasing complex-
ity or difﬁculty of cognitive tasks can be framed as a continuum; even if
the task complexity can be accurately quantiﬁed (e.g. linear increase in
the number of items to be remembered), the resulting increase in
neural processing should not be assumed to follow the same pattern.
Similarly, dose response relationships with neuroimaging data repre-
sent a continuum where the known dose interval may not match the
differences in brain states (Tauscher et al., 2002). This may be particu-
larly apparent when a small number of doses are used, or a newmech-
anism is being investigated. In all these examples, it would seem
desirable to make use of the ordinal relationships between class labels
to enable them to be more accurately predicted, compared to binary
or multi-class classiﬁcation approaches which ignore this information.
Here, we pose the question: how can we identify a state that is as-
sumed to be intermediate between multiple states? We propose
re-formulating this problem using a multivariate ordinal regression
framework which inherently models the natural ordering in the
data labels and can establish whether a collection of brain regions
are ordinally related across a continuum. Crucially, this framework
will consider all classes simultaneously and can be tested on a single
test case (we do not require a test instance for each class to decode
the ranking) in contrast to the only two previous ordinal ranking ap-
proaches for neuroimaging of which we are aware; Fan and ADNI
(2011) decomposed the problem into pairwise classiﬁers which
were then combined using an ordinal ranking rule while Pedregrosa
et al. (2012) proposed training a single binary classiﬁer to discrimi-
nate pairs of data vectors that exhaustively describe all pairs of clas-
ses. This method requires that a test case for each class must be
available to decode the ranking of the image. We focus in particular
on ordinal regression as conventional parametric or non-parametric
regression approaches enforce a metric notion or sense of symmetry
between labels. Consider the ordinal scale mild, medium and severe.
To use a regression approach we may encode these labels as [1, 2,
3]. However, this metric notion assumes that the difference between
mild and medium is the same as the difference between medium and
severe. Additionally, unlike multi-class classiﬁcation, which provides
a different set of predictive weights for each class the model structure
for an ordered class relation typically involves estimating a single set
of predictive weights which reﬂects the ordering of all the classes
(Chu and Ghahramani, 2005; Gutiérrez et al., 2012; Mccullagh,
1980). Moreover, performance metrics should be appropriately cho-
sen as for ordinal regression the ‘distance’ of the error from its true
label is of interest. That is, the magnitude of the error on incorrectly
classifying mild as severe should be more highly penalised than clas-
sifying mild as moderate.To investigate whether multivariate ordinal regression is a better
suited approach for data with ordered targets we utilise two exem-
plar pharmacological imaging studies. The ﬁrst study aims to investi-
gate the blood oxygen level-dependent (BOLD) response to ketamine
which acts as an N-methyl D-aspartate (NMDA) receptor antagonist
and evokes psychotomimetic symptoms resembling schizophrenia
in healthy humans (Krystal et al., 1994). Imaging markers of acute ke-
tamine challenge have the potential to provide a powerful assay of
novel therapies for psychiatric illness. In this data set, the modulation
of the BOLD response to ketamine is investigated using two com-
pounds — the anticonvulsant lamotrigine and the antipsychotic ris-
peridone (Doyle et al., 2013). In our earlier paper, we conﬁrmed
that both lamotrigine and risperidone attenuate the effects of keta-
mine on the BOLD phMRI signal, albeit via different mechanisms of
action (Doyle et al., 2013). We thus expect the class labels to be ordi-
nal with placebo and ketamine at the extremities and lamotrigine or
risperidone as the intermediate class. As this study was carried out
to explore the level of attenuation achieved by risperidone and com-
pare and replicate the attenuation of ketamine by lamotrigine, a priori
we cannot rank lamotrigine and risperidone in a meaningful, princi-
pled manner, hence we will apply the algorithms separately. The sec-
ond study focuses on the use of scopolamine which has been used for
many years as a pharmacological model of ‘cholinergic amnesia’
gaining popularity due to the cholinergic hypothesis of geriatric
memory dysfunction (Bartus et al., 1982), and the reversal of deﬁcits
is widely adopted as a tool to test putative cognitive-enhancing drugs.
This study utilises arterial spin labelling to investigate the effect of
scopolamine (a potent antagonist of the muscarinic acetylcholine re-
ceptor) on cerebral blood ﬂow and its modulation using donepezil, an
acetylcholinesterase inhibitor which can provide some improvement
in cognitive impairments in cholinergic animal models of Alzheimer's
disease as well as patients (Di Santo et al., 2013;Winblad et al., 2001).
Considering that scopolamine is a non-selective muscarinic acetyl-
choline receptor antagonist whereas donepezil will enhance choliner-
gic transmission to both nicotinic and muscarinic receptors we do not
expect the whole brain response to be ordinal as donepezil will pro-
duce speciﬁc regional CBF (rCBF) effects distinct from scopolamine.
Therefore, we expect donepezil to attenuate scopolamine effects in
regions which are rich in muscarinic receptors and have previously
shown a response to scopolamine. Hence we use ordinal regression
to explore the rCBF in predeﬁned regions of interest (ROIs). Previous
neuroimaging studies have shown both increases and decreases in ce-
rebral blood ﬂow following scopolamine administration, although
these effects were not derived from fully quantitative measurements
of blood ﬂow (Grasby et al., 1995; Honer et al., 1988; Prohovnik et al.,
1997). Work in experimental animals has demonstrated reduced CBF
following scopolamine (Ogawa et al., 1994; Tota et al., 2012), which
can be reversed by acetylcholinesterase inhibitors (Ogawa et al.,
1994; Tsukada et al., 1997). Therefore, we expect rCBF to be most
reduced following scopolamine administration and we expect rCBF
following pre-treatment with donepezil to lie between that of placebo
and scopolamine.
In this work, we describe a whole brain probabilistic approach for
ordinal regression using Gaussian processes (ORGP) in a Bayesian
framework. This framework provides probabilistic predictions for
class membership which facilitates the quantiﬁcation of uncertainty,
and an elegant approach for model selection and comparison. The
likelihood function of this method speciﬁcally captures the ordinal
nature of the data using a threshold model which is a generalisation
of the probit function as introduced by Chu and Ghahramani (2005).
We will compare this approach to schemes for multi-class classiﬁcation
and metric regression, in all cases linear learning algorithms will be
utilised. Comparisons will be carried out using three data conﬁgura-
tions: 1) BOLD data ranked increasingly as placebo, lamotrigine–
ketamine and ketamine, 2) BOLD data ranked increasingly as placebo,
risperidone–ketamine and ketamine and 3) ASL data ranked
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Recalling that the intermediate classes feature the compound of in-
terest (i.e. ketamine or scopolamine) administered in addition to a
modulatory pre-treatment (i.e. lamotrigine, risperidone or
donepezil), which would be expected to attenuate the effects of
the compound of interest.
Materials and methods
ORGPs — ordinal regression using Gaussian processes2
Here, we provide an insight into the mathematical concepts pro-
posed by Chu and Ghahramani (2005) which govern this approach
to ordinal regression. We refer the reader to Chu and Ghahramani
(2005) for a more detailed description of this method.
Consider a training data set D of N observations, D ¼ xi; yið Þ i ¼jf
1;…;Ngwhere each sample is a pair consisting of the input data vector
xof dimensionM and corresponding label yi ∈ Lwhere L is aﬁnite set of
R ordinal categories, denoted L = {1, 2, …R}. The column data vectors
for all N cases are aggregated in the data matrix X with dimensions
N × M and the targets are collected in vector y.
Themain principle here is to assume an unobservable latent function
f xið Þ∈R associated with each xi and assume a Gaussian process prior
over f, where f is a vector collecting all latent function values. The ordinal
variable yi is dependent on the latent function f(xi) by modelling the
ranks as intervals on the real line (Chu and Ghahramani, 2005). This is
achieved using a Bayesian framework. First, a Gaussian process prior
P(f|X, θ) is placed on the latent function. The Gaussian process prior
can be fully deﬁned by a mean functionm(x) and a covariance function
k(xi,xj). Here we deﬁne the GP as zero mean with a linear covariance
matrix:
K ¼ XXT þ 1
 
=s2
where s2 is a bias term that also controls the scaling of the latent function
which in turn affects the variance of the predictive weights. We refer to
this quantity as a hyperparameter, collected in the vector θ, which will
be optimised within this framework.
The joint probability of observing the ordinal variables, i.e. the
likelihood is deﬁned as
Pðy fj Þ ¼ ∏
N
i¼1
P yi f xið Þj Þ:ð
Under noise-free conditions, the ideal likelihood function would
be deﬁned as
Pidealðyi f xið Þj Þ ¼
1; if byi−1b f xið Þ≤byi
0; otherwise

where b represents a threshold variable. At the extremities these vari-
ables serve as limits and are deﬁned as b0 = −∞ and bR = +∞ and
the intermediate thresholds are further deﬁned as bj = b1 +∑l = 2j Δk
with positive padding variables Δkwhere k = 2,…,R − 1. This formula-
tion enforces ordinal constraints by dividing the real line into R contigu-
ous intervals (b1 b b2 b … b bR − 1) which map f(xi) to the discrete
variable yi. Note that the thresholds are not constrained to be equidistant.
A schematic illustration of the shape of the likelihood functions for a
three class problem is provided in Fig. 1.
Pideal(yi|f(xi)) assumes that the input data are noise-free. To
account for noise, we explicitly assume that the latent functions are
contaminated by Gaussian noise with zero mean and unknown vari-
ance σ2, denoted N δ;0;σ2  where δ is a Gaussian random variable.2 A MATLAB implementation of this method is available on request from the corre-
sponding author.The variance term here controls the shape of the likelihood function
serving to sharpen or soften the thresholds (see Fig. 1). The ordinal
likelihood function becomes
P yi f xið Þj Þ ¼ ∫Pideal yi f xið Þ þ δj ÞN δ;0;σ2
 
dδ ¼ Φ zi1
 
−Φ zi2
 
where zi1 ¼
byi−f xið Þ
σ and z
i
2 ¼
byi−1−f xið Þ
σ and Φ(z) is the cumulative unit
Gaussian whereby Φ zð Þ ¼ ∫z−∞N φ;0;1ð Þdφ.
Bayes' theorem can be used to compute the posterior probability,
hence enabling predictions to be made.
Bayesian framework
From Bayes' theorem the posterior probability distribution over
the latent function can be written as
Pðf y;X; θj Þ ¼ 1
Pðy X; θj Þ ∏
N
i¼1
P yi f xið Þj ÞP f X; θj Þðð
where the prior probability is deﬁned as P f X; θj Þ ¼ð
2πð Þ−N2 K −12 exp − 12 fTK−1f
  where K is the covariance matrix
and P(y|X, θ) = ∫P(y| f)P( f |X, θ)df, and θ is a vector that collects
the hyperparameters. To perform inference several model hyper-
parameters θmust be set. These include the covariance function param-
eter log(s2) (controlling the scale and bias) and the likelihood
parameters {b1, log(Δ2), …,log(ΔR − 1), log(σ)}. Note, that each
hyperparameter should be greater than zero except for b1, so to enforce
positivity we optimise all other variables in the log domain. The
normalisation factor P(y|X, θ) is known as the model evidence and is
the metric used to learn the hyperparameters. To approximate the
posterior distribution and model evidence we use the Laplace approxi-
mation at the maximum a posteriori (MAP) estimate (Williams and
Barber, 1998). This approach was found to perform similarly to an
expectation propagation approach across nine benchmark data sets
(Chu and Ghahramani, 2005). Powell's method is used to maximise the
evidence and hence, infer the optimal hyperparameters (Powell, 1964).
Having set the hyperparameters, we now want to make predic-
tions about a test case x* for which the target y* is unknown. Under
the Laplace approximation, the predictive distribution for the latent
function can be written as a Gaussian N f xð Þ; μ; ξ2
 
where the
predictive mean and variance can be written as
μ ¼ kTK−1 f^ and ξ2 ¼ k−kT Kþ Λ^
−1 −1k;
where k
*
is the covariance between the test case and the training data,
k
**
is the variance of the test case, f^ is the MAP estimate of the latent
function, Λ^ is a diagonal matrix whose ii-th entry is second derivative
of the likelihood function training sample i with respect to f(xi).
The predictive distribution over the ordinal target y* is
Pðy x;X; y; θj Þ ¼ Φ
by−μﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2 þ ξ2
q
0
B@
1
CA−Φ by−1−μﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2 þ ξ2
q
0
B@
1
CA:
This distribution is used to assign the test case to an ordinal scale
using
argmaxr∈RP y ¼ r x;X; y; θj Þ:ð
Multi-class classiﬁcation
Here we present two approaches for multi-class classiﬁcation
using Gaussian processes. The ﬁrst involves forming pairwise binary
classiﬁers and computing the test label for an unseen test case using
error correcting codes while the second is an inherently multi-class
Fig. 1. Ordinal regression likelihood functions for a problem with three ordinal classes (R = 3) and hence two threshold variables with b1 = −6 and b2 = 6 and two extremity
threshold constants b0 and b3 which are set to − ∞ and + ∞, respectively. The case for the noise parameter σ = 1 appears in boldfaced blue and two additional greyed out func-
tions are displayed for σ = 0.01 (approximating the noise-free case) and σ = 2.
Table 1
Probabilistic code words for each class. C1 — class 1, C2 — class 2 and C3 — class 3. ‘0’
implies that the output from the binary classiﬁer is expected to be the ﬁrst class listed.
Similarly, ‘1’ implies the second class listed. ‘0.5’ implies that the classiﬁer is neutral, for
example testing an instance from class 3 on the classiﬁer trained on class 1 and class 2.
Binary classiﬁer pairs
C1 × C2 C1 × C3 C2 × C3
C1 0 0 0.5
C2 1 0.5 0
C3 0.5 1 1
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approaches have been used to provide a comprehensive comparison
of ORGP with multi-class classiﬁcation.
Pairwise multi-class classiﬁcation using Gaussian processes (PMCGPs)
This approach involves solving themulti-class classiﬁcation problem
using binary classiﬁers where all pairs of classes are compared to each
other. Given a three class problem we can build three unique pairwise
classiﬁerswhere each binary classiﬁer votes for either of the two classes
it was trained on to produce a 3-bit predicted code. In order to assign a
label to a test case, error correcting codes were usedwhereby each class
is assigned a unique codeword and its distance from the predicted
code word is computed (Dietterich and Bakiri, 1995). The test case is
assigned to the class with the minimum distance from its pre-deﬁned
codeword. Here, binary classiﬁcationwas implemented using Gaussian
process learning as described by Rasmussen and Williams (2006) and
provides probabilistic measures of class membership. Therefore, proba-
bilistic code words were used, see Table 1.
Multi-class classiﬁcation using Gaussian processes (MCGP)
Gaussian process classiﬁcation can be extended from the binary case
using a multi-class analogue of the logistic function (the response func-
tion which maps the values of the latent function onto [0 1] to produce
probabilities) — i.e. the softmax function (Williams and Barber, 1998).
Here, we provide a brief summary of the mathematical concepts intro-
duced byWilliams and Barber forMCGPbut refer the reader toWilliams
and Barber (1998) and Rasmussen and Williams (2006) for a more de-
tailed description. In this case, an independent latent function is used to
model the probability of each class.
Consider a vector of latent function values at all training points N
and for all R classes
fMC ¼ f 11;…; f 1N ; f 21;…; f 2N ;…; f R1;…; f RN
 
where fMC has length RN, i.e. each class has a corresponding set of N
latent variables. As before, the prior over f MC has the form fMCeN 0;Kð Þ:
Assuming that the latent variables for each class are uncorrelated, thecovariance matrix K is a block diagonal in the matrices K1, …,KR. Each
individual matrix Kr expresses the covariance of the latent function for
each class r using an individual covariance hyperparameter sr2 to control
the variance and bias so that,
Kr ¼ XXT þ 1
 
=s2r :
Let πir denote the output of the softmax function at training sam-
ple i
pðyi ¼ rjfMCi Þ ¼ πri ¼
exp f ri
 
∑Rd¼1exp f di
 
where fiMC is a vector of length R describing the latent function values
across all classes for training sample i. This formulation enforces the
constraint∑r = 1R πir = 1.
As in the binary case and for ordinal regressionwe seek themaximum
a posteriori value f^
MC
of the posterior P(fMC|y, X, θ) which is achieved
using Newton's method as described in Rasmussen and Williams
(2006). The Laplace approximation is then used to compute the posterior.
As in the ordinal regression approachweuse Powell'smethod to optimise
the hyperparameters of the covariance function. To compute the predic-
tive distributionwe apply the softmax function to the approximated pos-
terior distribution of the latent function evaluated at the test point. For
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predictive mean, however, for multi-class classiﬁcation we need to
take the variance of themean into account, which is computed by a sim-
ple Monte Carlo procedure as in Rasmussen and Williams (2006).
Metric regression
Metric regression was implemented using ridge regression (RR)
which involves linear least square regression with Tikhonov
regularisation (Bishop, 2006). Here, RR was implemented using the
dual representation, i.e. learning is performed in the dimension of
samples rather than features. It is therefore equivalent to the kernel
ridge regression approach described for neuroimaging data by Chu
et al. (2011) using the formulation,
α ¼ XXT þ λI
 −1
y−yð Þ
where λ controls the level of regularisation and y is the (scalar) mean
across all training labels. To encode the ordinal relationship across the
three classes the labels [1 2 3] are used, in keeping with the data
labels used for the ORGP approach. Predictions are made using
y ¼ kTα þ y
where y* are the real-valued predictions. To force the metric predic-
tions to deﬁne distinct three-class categories we use a somewhat
ad-hoc approach which involves rounding the predictions to the
nearest integer; if this integer is 1 or 2 or 3 then the class label is di-
rectly assigned whereas if the integer is 0 it is assigned to class 1 and
if the integer is greater than 3 it is assigned to class three. We
assessed the effect of the regularisation parameter across a range of
values and we found that the accuracy was insensitive to the value
of particular setting of λ, therefore in keeping with Chu et al. (2011)
we set λ to 10e−5.
Multivariate whole brain maps
For the Gaussian process algorithms which consider all classes si-
multaneously (i.e. ORGP and MCGP but not PMCGP) multivariate
maps were constructed to visualise the spatial pattern driving the re-
gression or classiﬁcation. For GP learning, this is achieved by
visualising the MAP estimate of the weight vector to provide a spatial
representation of the decision boundary. This is analogous to the
weight vector used for mapping SVM discrimination (Marquand et
al., 2010). For both MCGP and ORGP we can extract a vector α,
which is analogous to the weight vector in the function-space view
of GP learning (Rasmussen and Williams, 2006), whereby α = K−1f.
To our knowledge, this is the ﬁrst paper to introduce discrimina-
tive mapping for ordinal regression using Gaussian processes. For
ORGP, the maps are constructed by computing the posterior expecta-
tion w^ of the weight vector in the weight-space
w^ ¼ 1
s2
XTα:
For MCGP, the MAP expectation of the weights can be derived
similarly for each class. Since multivariate techniques are sensitive
to spatial correlation, and the performance of the classiﬁer is based
on the entire pattern rather than individual voxels, inference based
on local regions should be avoided when interpreting these maps.
Implementation of pattern recognition techniques
All algorithms were trained in a leave-one-out cross-validated man-
ner, whereby data from all but one of the participants were used totrain the model and the ﬁnal (unseen) participant's data were used for
testing.
As ordinal regression is used to predict the ordering of unseen
data, we will present the results using familiar classiﬁcation metrics
(e.g. accuracy, confusion matrices) but also metrics that are designed
to appropriately penalise the errors made when predicting rank
(mean absolute error and Kendall's tau).
We use confusion matrices as visualisation tools. For confusion
matrices, the rows represent the true class labels and the columns
represent the labels predicted by the learning machine. The diagonal
elements represent correctly classiﬁed test cases whereas the
off-diagonal elements represent misclassiﬁcations. Thus, this matrix
represents the performance of the learning machine on a per-class
basis and also enables us to visualise the magnitude of the errors,
i.e. errors between adjacent classes versus errors in more distal clas-
ses. The accuracy is calculated from this matrix by dividing the sum
along the diagonal by the sum of all cells. The per class sensitivities
are deﬁned as the number of true positives divided by the sum of
the number of true positives and false negatives. The positive predic-
tive value (PPV) the probability of belonging to a particular class
given that class membership was assigned by the algorithm. It is cal-
culated as the number of true positives divided by the number of true
positives and false positives.
Mean absolute error (MAE) is the average deviation of the predict-
ed label from the true label wherebyMAE ¼ 1N∑Ni¼1 yi− yð Þi
 j; where
N is the total number of samples and (y*)i is the predicted label for
sample i. Note, for RR MAE is calculated from the real-valued predict-
ed outputs to capture its behaviour in a ﬁne-grained manner. The
rank correlation coefﬁcient between the predicted label and the true
label was calculated using Kendall's tau statistic (Kendall, 1938).
In the context of probabilistic models, the theoretically optimal
quantity for model comparison is the marginal likelihood, which pro-
vides an optimal trade-off between model ﬁt and complexity under
the assumptions of the model. However, to compare different models
using the marginal likelihood it is necessary to also account for differ-
ent numbers of hyperparameters by integrating them out or
penalising models with a larger number of parameters. In GP models,
the hyperparameters can only be integrated out using Markov chain
Monte Carlo methods, which are relatively computationally demand-
ing. Therefore, in the present work we adopt an alternative approach
to compare the ordinal regression model to the explicitly multi-class
model (MCGP). Speciﬁcally, we penalise the marginal likelihood by
the number of parameters to construct both the Akaike information
criterion (corrected for ﬁnite sample size) (Akaike, 1974) and the
Bayesian information criterion (Schwarz, 1978). Both of these mea-
sures are widely used in neuroimaging and assess model ﬁt while ac-
counting for model complexity (in this case, the number of
hyperparameters) which is important here as ORGP has an additional
hyperparameter relative to MCGP. However, the Bayesian informa-
tion criterion penalises complexity more strongly. Note that the
MCGP is parameterised using three hyperparameters (one per
class). However, the constraint that the class probabilities must sum
to one introduces a redundancy such that the likelihood can be equiv-
alently represented using two hyperparameters by ﬁxing the latent
function values for one of the classes (the reference class) to one.
Therefore, to be conservative we penalise the MCGP likelihood by
two (rather than three) parameters to compute the information
criteria although we note that both approaches lead to the same
conclusions.
All algorithms were implemented in MATLAB (The MathWorks,
Natick, Massachusetts). For ORGP, custom likelihood and inference
scripts were written for compatibility with the GPML toolbox
(Rasmussen and Nickisch, 2010). MCGP was implemented as
per the PRoNTo toolbox (Schrouff et al., in press). PMCGP was
implemented using customised scripts also from the PRoNTo
toolbox.
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Statistical signiﬁcance was assessed by testing if the accuracies
achieved were greater than chance (33%) using permutation test-
ing. The class labels were randomly permuted 1000 times and the
learning algorithms (ORGP, PMCGP, MCGP and RR) were
re-trained using these labels. The number of times the permuted
accuracy was greater than the true accuracy was counted and di-
vided by the number of permutations to produce a p-value. To as-
sess the difference between the accuracy achieved for ORGP
versus all other algorithms the permuted difference in accuracies
was computed. The number of times the permuted difference was
greater than the true difference was divided by the number of
permutations to produce a p-value.
Ketamine study
Sixteen healthy male participants (mean age 25.8 years; SD = 5.7;
range 20–37)with noprevious neurological or psychiatric illness or his-
tory of alcohol or drug abuse were recruited and completed four scan-
ning sessions. All participants gave written informed consent. The
study was approved by Wandsworth Research Ethics Committee (09/
H0803/48). Further details for the participants and experimental proce-
dures are available in Doyle et al. (2013). The design is brieﬂy
summarised below.
This randomised placebo-controlled, double-blind, partial cross-
over design involved screening and four scanning visits. For each
scanning visit, participants received: placebo (ascorbic acid) and sa-
line infusion, placebo and ketamine infusion, lamotrigine (300 mg)
and ketamine infusion and risperidone (2 mg) and ketamine infusion.
The oral drugs were administered in identical capsules approximately
3 h prior to ketamine infusion.
Image acquisition
Participants were scanned using a 3.0T General Electric Signa
HDx scanner (GE Medical Systems, Milwaukee, WI, USA). A 15-minute
eye-open resting-state BOLD phMRI scan was acquired using
gradient-echo echo-planar imaging (EPI). 450 image volumes of 38
near-axial slices (3 mm thickness, interslice gap of 0.3 mm) were ac-
quired per session (TE/TR = 30/2000 ms, ﬂip angle (FA) = 75°,
in-plane resolution = 3.3 mm, matrix size = 64 × 64, ﬁeld of view =
21.1 cm × 21.1 cm). A higher resolution gradient echo scan was also
acquired (43 3 mm-thick near-axial slices with 0.3 mm gap, TE/TR =
30/2000 ms, FA = 90°, in-plane resolution = 3.3 mm, matrix size =
128 × 128, ﬁeld of view = 24 cm × 24 cm).
Image pre-processing and modelling
The data were pre-processed using SPM5 (www.ﬁl.ion.ucl.ac.uk/
spm). This involved slice-timing correction, realignment, co-registration
to the high-resolution image, spatial normalisation to the SPM EPI
template using parameters derived from non-linear normalisation
of the high-resolution image, and spatial smoothing (8 mm FWHM
Gaussian kernel). A high-pass ﬁlter with a cut-off of 1200 s (twice
the post infusion phMRI scan duration) was applied to the data to
minimise the inﬂuence of very low frequency noise.
First-level modelling was performed in a general linear model
framework as described previously (De Simoni et al., 2013). The
design matrix comprised four regressors: 1) a gamma variate func-
tion parameterised to capture the BOLD response to a ketamine infu-
sion in an independent cohort (for further details see De Simoni et al.
(2013)), 2) the ﬁrst component of a singular value decomposition of
the six head motion traces, 3) a regressor to capture variations in
the shape of the phMRI regressor and 4) a linear drift term. The
beta images from the contrast of the gamma variate regressor were
used as inputs for the pattern recognition analysis. These imagescontained 178,898 in-brain voxels across all 16 subjects. Here, we
will apply our algorithms to the data using two conﬁgurations:
1. class 1: placebo–saline session, class 2: lamotrigine–ketamine
and class 3: placebo–ketamine
2. class 1: placebo–saline session, class 2: risperidone–ketamine
and class 3: placebo–ketamine.
For brevity, we will refer to conﬁguration 1 as the lamotrigine
case and conﬁguration 2 as the risperidone case. As mentioned in the
Introduction,we cannot rank lamotrigine and risperidone in ameaning-
ful, principled manner, hence we will apply the algorithms separately.
Scopolamine
15 healthy male volunteers (mean age 24.9 years; SD = 6.6;
range 19–43) participated in a three period Latin-square design
study, and were administered oral placebo and saline (s.c.), placebo
and scopolamine (0.2 mg s.c.; SCOP) or donepezil (5 mg p.o.) and
scopolamine. The donepezil and placebo were administered in identi-
cal capsules. Whole brain rCBF was measured using pulsed-continuous
ASL (pCASL). Participants passed a screening period as described for the
ketamine study above and the study was approved by the Institute of
Psychiatry and South London and Maudsley NHS Trust Research Ethics
Committee (06/Q0706/52).
Image acquisition
Subjects rested in the scanner while a single whole brain cerebral
blood ﬂow map was acquired using a pulsed-continuous ASL se-
quence (Dai et al., 2008). In this technique, arterial blood is labelled
using a long (1.5 s) train of Hanning-shaped radio frequency pulses
of 500 μs duration and 500 μs inter-pulse gap. This method labels
the longitudinal magnetisation of arterial blood by means of a
ﬂow-driven, adiabatic inversion in the presence of a net magnetic
ﬁeld gradient of 0.07 G cm−1. After a post-labelling delay of 1.5 s,
the images were acquired with a 3D spiral multi-short readout (TE
4 ms, TR 5500 ms, ETL 64). CBF maps (in standard physiological
units (millilitres of blood per 100 g of tissue perminute))were comput-
ed with a spatial resolution of 1 × 1 × 3 mm. Three pairs of tagged–
untagged images were collected; which together with two reference
volumes for ﬂow quantiﬁcation, required a total acquisition time of
6:08 min. A high-resolution, anatomical T2-weighted scan was also
acquired. This scan was collected with a Fast-Spin echo protocol (echo
train length 19, TE/TR of 54.48/4380 ms); ﬁeld of view 24 cm, 72 near
axial slices along the AC–PC axis with 2 mm thickness and zero gap,
were collected. The ﬁnal in-plane resolution of the image was
1 × 1 mm.
Image pre-processing and region of interest deﬁnition
Extra-cerebral signal from the T2 structural scan was removed
using the brain extraction tool included in FSL (Smith, 2002) and
the skull-stripped T2 image and its corresponding binary mask were
co-registered to each pCASL image using SPM5. Then the brain mask
derived from the T2 image was applied to each pCASL image and
the resulting skull stripped images were then co-registered back to
the original T2 image. Finally, the high resolution T2 image was
used to compute SPM5 normalisation parameters necessary to warp
the image to the T2 MNI template provided with SPM5 and the
resulting parameters were applied to the co-registered pCASL images
in addition to the T2 image. Following normalisation, each whole-brain
pCASL imagewas spatially smoothed (8 mm isotropic Gaussian kernel).
Since, global basal rCBF values are potentially different between partic-
ipants, each image was then mean-centred within participants.
To date, the authors are aware of only two studies describing the
effect of donepezil pre-treatment on scopolamine in healthy volun-
teers, both of which involve cognitive paradigms (Lenz et al., 2012;
Snyder et al., 2005). Therefore, we use the literature on scopolamine
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(Grasby et al., 1995; Sperling et al., 2002). Following scopolamine
administration, Grasby et al. (1995) reported sites of altered rCBF
(measured using positron emission tomography) in the occipital cor-
tex, thalamus, precuneus and premotor area. In keeping with the work
of Grasby et al. (1995) and studies in the primate (Asai et al., 2009;
Yamamoto et al., 2011), we have selected the thalamus and occipital
cortex as regions of interest. Additionally, we have selected the anterior
cingulate cortex (ACC) which receives intense cholinergic innervation
from a collection of cells in the basal forebrain (Mesulam, 1995) and
therefore we hypothesized that rCBF in the ACC would be altered by
scopolamine and its modulation with donepezil.
Here,wewill apply our algorithms to the data using the conﬁguration:
class 1: placebo–saline, class 2: donepezil–scopolamine and
class 3: placebo–scopolamine
For brevity, we will refer this conﬁguration as the donepezil case.
Results
Ordinal regression (ORGP), multi-class classiﬁcation (PMCGP and
MCGP) and metric regression (RR) were applied to brain imaging data
to provide predictions of class membership (probabilistic in the case of
ORGP and MCGP). We compare the performance of these algorithms
across pharmacological imaging data sets for which we expect an ordinal
relationship to exist. For the BOLD data we use whole brain data from
the placebo and ketamine sessions at the extremities with either
lamotrigine or risperidone as the intermediate class. For the ASL data
we explore the behaviour in three ROIs across the placebo and scopol-
amine session at the extremitieswith donepezil as the intermediate class.
Ketamine Study
The performance of all techniques is displayed as confusionmatrices
in Fig. 2 and the accuracy, mean absolute error (MAE), Kendall's tau,
model evidence and information criteria are reported in Table 2 (note
that the chance level for a three-class problem is 33.3%). For ORGP, con-
sidering lamotrigine as the intermediate class resulted in amean classi-
ﬁcation accuracy across all three classes of 72.9% with sensitivities
(PPV) of 5% (75%), 62.5% (62.5%) and 81.3% (81.3%) for placebo,
lamotrigine and ketamine, respectively. In Fig. 2, we can see that for
the placebo class, four scans were misclassiﬁed. However, the errors
were conﬁned to the adjacent class — lamotrigine. For ketamine, three
scans were misclassiﬁed two of which occurred for the adjacent classFig. 2. Confusionmatrices using both lamotrigine (LAM) and risperidone (RIS) as the intermedi
with bright colouring in the diagonal and dark colouring off-diagonal indicates good perfor
ORGP, (c) placebo–lamotrigine–ketamine for PMCGP, (d) placebo–lamotrigine–ketamine for
PMCGP, (g) placebo–risperidone–ketamine for MCGP and (h) placebo–risperidone–ketaminewith only one assigned to themore distant placebo class. Themisclassi-
ﬁcations for lamotrigine were distributed evenly across the adjacent
classes. However, the misclassiﬁcation errors tended to occur for the
classes at the extremities with seven of placebo scans and 6 of the keta-
mine scans misclassiﬁed. ORGP signiﬁcantly outperformed all other
techniques considering the MAE (p = 0.035, 0.014, 0.04, for PMCGP,
MCGP and RR, respectively). Additionally, PMCGP and MCGP but not
RR were signiﬁcantly less accurate than ORGP (p = 0.03 and p =
0.04, respectively, by permutation test) in discriminating the groups
with overall accuracies of 60.4%, 56.3% and 70.8%, respectively. Crucial-
ly, for both multi-class approaches only one of the scans belonging to
the intermediate class was correctly labelled (Fig. 2). Similarly for RR,
the misclassiﬁcations were less evenly distributed amongst classes
than for ORGP.
Considering risperidone as the intermediate class, the mean ac-
curacy across the three classes was 60.4% for ORGP which is similar
to the mean accuracy for both multi-class approaches which was
56.3%. Additionally, similar levels of performance were observed
for MAE and Kendall's tau, Table 2. However, the distribution of
the errors across the classes sets the techniques apart: for both
multi-class approaches none of the risperidone scans are labelled
correctly, see Fig. 2. Unlike the multi-class schemes RR achieved cor-
rectly identiﬁed 11 out of 16 of the risperidone scans however, the
true positive for the placebo class was much reduced with ORGP
found to signiﬁcantly outperform RR in terms of accuracy and
MAE, (p = 0.04 and p = 0.001, by permutation).
For ORGP and MCGP, the Akaike and Bayesian information criteria
were lower for the ordinal regression models in both cases, indicating
that these ordinal models were favoured over the multi-class ap-
proach. Whole brain maps for the lamotrigine and risperidone cases
can be observed in Fig. 3. For ORGP, this map visualises the projection
of the data along the function space weight vector (α) moving from
the placebo state right through the ketamine state. Qualitatively, the
maps generated by ORGP for both lamotrigine and risperidone are
similar (see Fig. 3). For MCGP, none of the lamotrigine/risperidone
classes were correctly classiﬁed, so the weight maps for these classes
are not meaningful. Therefore, we only present the maps for the pla-
cebo and ketamine classes.Scopolamine study
Here, we focus on two cortical regions (anterior cingulate cortex
and occipital lobe) and a sub-cortical region (thalamus). As before,ate class for ORGP, PMCGP,MCGP and RR. The greyscalewhich is provided for visualisation
mance. (a) Visualisation of the ideal confusion, (b) placebo–lamotrigine–ketamine for
RR, (e) placebo–risperidone–ketamine for ORGP, (f) placebo–risperidone–ketamine for
for RR.
Table 2
Performance metrics for ordinal regression (ORGP) and pairwise multi-class classiﬁcation (MCGP), multi-class classiﬁcation (MCGP) and ridge regression (RR). Model evidence is
quantiﬁed using the negative marginal log likelihood computed using the entire data set. LAM: lamotrigine, RIS: risperidone, MAE: mean absolute error, AIC: Akaike information
criterion, and BIC: Bayesian information criterion.
Performance metric LAM (ORGP) LAM (PMCGP) LAM (MCGP) LAM (RR) RIS (ORGP) RIS (PMCGP) RIS (MCGP) RIS (RR)
Accuracy 72.9%⁎†‡ 60.4%⁎ 56.3%⁎ 70.8%⁎ 60.4%⁎§ 56.3%⁎ 56.3%⁎ 50.0%⁎
MAE 0.29†‡§ 0.46 0.52 0.40 0.44§ 0.50 0.50 0.61
Kendall's tau 0.70 0.61 0.53 0.71 0.57 0.61 0.61 0.46
Model evidence 39.0 – 44.6 – 40.4 45.6
AIC 86.9 – 93.5 – 89.7 95.5
BIC 93.5 – 96.9 – 96.3 98.9
⁎ Accuracy > chance (33%) p b 0.05.
† ORGP outperforms PMCGP p b 0.05.
‡ ORGP outperforms MCGP p b 0.05.
§ ORGP outperforms RR p b 0.05.
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matrices in Figure S1 and using a collection of metrics in Table 3.
For the ACC ORGP was found to signiﬁcantly outperform all other
techniques in terms of classiﬁcation accuracy and also MAE. Notably,
for the anterior cingulate, ORGP achieves over a 20% increase in
classiﬁcation performance relative to all other approaches. For the
thalamus, ORGP outperformed PMCGP in terms of accuracy (p =
0.002) and both PMCGP and RR in terms of MAE (p = 0.007 and p =
0.039, respectively). Conversely, similar performance was observed
across all techniques for the occipital lobe. A potential explanation for
this result can be observed from Figure S2 which displays the average
pCASL signal for each ROI. For both the ACC and thalamus, in a qualita-
tive sense, we observe a decreasing rCBF ordinal response from placeboFig. 3.Multivariate maps extracted from both ORGP andMCGP. For ORGP, a single weight ma
maps with signiﬁcant classiﬁcation accuracy were computed. For visualisation, each map i
weight vector for all three classes. ORGP:PRK — ordinal regression weight vector for all thre
classiﬁcation weight vector for the placebo class considering lamotrigine as the intermediat
considering lamotrigine as the intermediate class. MCGP:PLARIS — multi-class classiﬁcation
MCGP:KETRIS — multi-class classiﬁcation weight vector for the ketamine class considering rto scopolamine with increased overlap between classes observed for
the ACC. However, the group-level rCBF for the occipital lobe donepezil
pre-treatment appears to have reversed the decrease in rCBF resulting
in no visually obvious ordinal response.
Discussion
We have presented a multivariate ordinal regression methodology
for neuroimaging data. We have demonstrated the efﬁcacy of this
novel analysis method in the context of two pharmacological imaging
studies. Amongst the approaches evaluated, ORGP was the only ap-
proach that performed well in all comparisons and produced higher
or equivalent accuracy and mean absolute error to the optimalp is produced whereas, for MCGP a weight map can be computed per class. Only weight
s scaled so that its maximum (absolute) intensity is 1. ORGP:PLK — ordinal regression
e classes considering risperidone as the intermediate class. MCGP:PLALAM —multi-class
e class. MCGP:KETLAM — multi-class classiﬁcation weight vector for the ketamine class
weight vector for the placebo class considering risperidone as the intermediate class.
isperidone as the intermediate class.
Table 3
Performance metrics for ordinal regression (ORGP) and pairwise multi-class classiﬁca-
tion (MCGP), multi-class classiﬁcation (MCGP) and ridge regression (RR). Model evi-
dence is quantiﬁed using the negative marginal log likelihood computed using the
entire data set. MAE — mean absolute error, AIC: Akaike information criterion, BIC:
Bayesian information criterion, and DON: donepezil.
Performance
Metric
DON
(ORGP)
DON
(PMCGP)
DON
(MCGP)
DON
(RR)
Anterior
cingulate
Accuracy 73.3%⁎†‡§ 40.0%⁎ 51.1%⁎ 42.4%⁎
MAE 0.29†‡§ 0.73 0.51 0.69
Kendall's tau 0.70 0.21 0.53 0.32
Model evidence 24.8 – 38.8 –
AIC 58.6 – 86.6 –
BIC 64.8 – 92.8 –
Occipital lobe Accuracy 64.4%⁎ 64.4%⁎ 60.0%⁎ 64.4%⁎
MAE 0.378 0.40 0.46 0.38
Kendall's tau 0.63 0.59 0.52 0.60
Model evidence 27.7 – 35.9 –
AIC 64.4 – 80.8 –
BIC 70.6 – 87.0 –
Thalamus Accuracy 80.0%⁎† 60.0%⁎ 68.9%⁎ 66.7%⁎
MAE 0.20†§ 0.42 0.31 0.36
Kendall's tau 0.81 0.60 0.72 0.66
Model evidence 20.8 – 29.8 –
AIC 50.6 – 68.6 –
BIC 56.8 – 74.8 –
⁎ Accuracy > chance (33%) p b 0.05.
† ORGP outperforms PMCGP p b 0.05.
‡ ORGP outperforms MCGP p b 0.05.
§ ORGP outperforms RR p b 0.05.
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classiﬁcation, ordinal regression and metric regression were able to
classify the ordinal groups with accuracies signiﬁcantly above chance.
The ORGP approach presented here considers all classes simulta-
neously in a Bayesian framework affording probabilistic predictions
and an elegant approach to model selection. Here, we draw particular
comparison with an algorithmically similar multiclass approach:
ordinal regression signiﬁcantly outperformed the inherently multi-
class approach for lamotrigine (72.9% vs. 56.3%, p = 0.014) while a
similar performance across both techniques was observed for risper-
idone (60.4% vs. 56.3%). Crucially, for the intermediate classes, the
true positive rates obtained for ORGP were 62.5% and 50% for
lamotrigine and risperidone (chance level is 33.3%) but in the case
of MCGP they were reduced to 6.3% and 0%, respectively. Moreover,
both the Akaike and Bayesian information criteria were lowest for
the ordinal regression models having conservatively penalised for
the number of hyperparameters. Metric regression (ridge regression)
was found to perform similarly to ordinal regression for lamotrigine
whereas for risperidone the accuracy for ORGP was signiﬁcantly
higher; recalling that for RR the approach to achieve categorical labels
is ad-hoc. Additionally, for the scopolamine data set ORGP signiﬁcant-
ly outperformed all other approaches for the anterior cingulate cor-
tex. Note, we also implemented Gaussian process regression,
however, the method did not perform in a stable manner which we
attribute to the highly non-Gaussian nature of the encoded labels
(i.e. a high degree of model mis-speciﬁcation).
While our exemplar analysis is based on psychopharmacological
data, many neuroimaging studies involve ordinal scales, for which
we cannot explicitly quantify the distance between classes. As men-
tioned in the Introduction, this might include complexity of a cogni-
tive task, clinical status, visual analogue scales (subjective states),
pain intensity, disease progression/transition and genetic dosage to
name some examples. To date, we are aware of only two other neuro-
imaging studies that investigate the use of ordinal schemes for their
data. Fan and ADNI (2011) applied an ordinal ranking approach to
the ADNI data set with the hypothesis that an ordinal approach is
more appropriate for the automatic identiﬁcation of the followingfour class labels — healthy controls, mild cognitive impairment
non-converter, mild cognitive impairment converter and Alzheimer's
disease. Fan proposed a method that divides the ordinal regression
problem into a series of binary ‘larger than’ classiﬁers and compared
it to a multi-class classiﬁer formulated using one-against-one binary
pairs of classiﬁers. While the overall accuracies for the ordinal and
multi-class approaches did not differ, the distribution of the errors
was evenly spread across all four classes for the ordinal approach
but skewed towards both MCI classes in the case of the multi-class
classiﬁer. This trend is similar to the results reported here whereby
for some cases the accuracy for the intermediate classes shows a
marked improvement on using an ordinal approach. Pedregosa et al.
(2012) investigated the use of presenting all possible class-wise
pairs of images to a binary classiﬁer in order to encode information
about the ordinal relationship between the class labels. This approach
was investigated using fMRI data acquired while subjects were listen-
ing to sentences with ﬁve increasing levels of complexity. The authors
conclude that the analysis revealed a non-linear relationship between
the BOLD signal response and the level of complexity. However, fur-
ther validation is warranted to fully understand the potential of
their technique. Moreover, Pedregosa's approach requires that test
cases for each possible class be available in order to decode the rank-
ing label.
Here, we have presented a novel whole brain approach to ordinal
regression that considers all classes simultaneously, which is distinct
from previous studies to date (Fan and ADNI, 2011; Pedregosa et al.,
2012). The implementation provides an explicit probabilistic model,
which is formulated in a Gaussian process framework that provides
ﬂexibility in quantifying the pair wise similarity between samples,
e.g. linear and non-linear kernels. Kernel methods such as Gaussian
process methods are computationally advantageous when the input
features exist in a high dimensional space, as is the case for neuroim-
aging data, because they enable us to work in dimensions of samples
rather than features. While not explored here, kernel methods also
provide an elegant method for the combination of multimodal data
(Gonen and Alpaydin, 2011). The application of learning algorithms
in a neuroimaging context is often an ill-posed problem, as the num-
ber of features (voxels) generally greatly outnumbers the number of
samples (scans). To help alleviate the possibility of overﬁtting, we
have employed algorithms that incorporate regularisation examples
which include penalising complexity and reducing the data to a sub-
set of relevant features. Achieving an optimal balance between ﬁtting
the training data and penalising the magnitude of the coefﬁcients is
paramount (Ashburner and Kloppel, 2011). The Bayesian framework
used here provides an elegant solution to regularisation by integrat-
ing out the parameters of the model, instead of estimating only the
hyperparameters. Moreover, we have restricted the hypothesis
space by choosing a linear classiﬁer.
The multivariate whole brain maps computed for ORGP displayed
patterns similar to a placebo vs. ketamine (visual inspection) response,
as observed using binary Gaussian process classiﬁcation (Doyle et al.,
2013). Additionally, the MCGP maps extracted for the ketamine class
are also highly similar to ORGP maps. This may indicate that a similar
set of features are highly weighted in the context of multi-class/binary
classiﬁcation and ordinal regression across the continuum. Therefore,
while both techniques weight the same set of features in a similar
fashion, ordinal regression affords increased sensitivity over MCGP by
explicitly modelling the ranking of the classes as evidenced by its supe-
rior performance across a range of metrics — accuracy, mean absolute
error and information criteria. One of the data sets employed here in-
volves the administration of the compound ketamine, which is known
to cause a widespread but selective activation across brain regions (De
Simoni et al., 2013). Conversely, for the scopolamine data we anticipat-
ed that altered rCBF and its modulation with donepezil may only occur
in areas rich in M2 receptors and therefore we chose regions of interest
appropriately. However, when limited prior knowledge is available
356 O.M. Doyle et al. / NeuroImage 81 (2013) 347–357with regard to the spatial distribution of the responsewe suggest apply-
ing ordinal regression locally using a searchlight approach (Kriegeskorte
et al., 2006) to provide the whole brain accuracy or mean absolute error
maps. Given the local nature of their computation, local inference could
be applied to these maps to establish where the imaging data is most re-
lated to the ordinal target. Another interesting avenue for future work
would be to develop an approach to enforce sparsity over the voxel coef-
ﬁcients, which may be useful to help localise discriminating brain
regions.
In summary, we have presented an application of probabilistic
multivariate ordinal regression to neuroimaging data. To rigorously
validate this proposal we would need to apply this technique to addi-
tional data sets that focus on varied applications such as disease pro-
gression and cognitive decoding. However, using pharmacological
imaging data as an exemplar, we have conﬁrmed that in some cases
presented here ordinal regression outperforms multi-class classiﬁca-
tion schemes as well as metric regression, particularly for the inter-
mediate classes. This suggests that the methodology presented here
may afford increased sensitivity for a wide range of neuroimaging
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